View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/FDA | RIN: 0910-AI06 | Publication ID: Fall 2019 |
Title: ENDS Safety Standards, Including Standards for Toxicants and Impurities in Nicotine, Propylene Glycol, and Vegetable Glycerin Used in E-Liquids; Tobacco Product Standard | |
Abstract:
The Food and Drug Administration is proposing regulations to establish tobacco product standards for electronic nicotine delivery systems (ENDS), to include, among other things, standards for nicotine, propylene glycol, and vegetable glycerin purity in e-liquid. This rule, if finalized, would, among other things, establish limits on the level of toxicants and impurities found in nicotine, propylene glycol, and vegetable glycerin. Toxicants and impurities found in nicotine, propylene glycol, and vegetable glycerin can cause death or other adverse health effects, and this rule would establish limits on the level of those toxicants that are appropriate for the protection of public health. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: No | Unfunded Mandates: No |
EO 13771 Designation: Regulatory | |
CFR Citation: 21 CFR 1172 | |
Legal Authority: 21 U.S.C. 331, 371(a), 381(e), 381(p)(2), 387b, 387c, 387f(d), 387g, 387i 21 U.S.C. 371(a) 21 U.S.C. 381(p)(2) 21 U.S.C. 387b and 387c 21 U.S.C. 387f(d) 21 U.S.C. 387g 21 U.S.C. 387i |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Small Entities Affected: Businesses | Federalism: No |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Nathan Mease Regulatory Counsel Department of Health and Human Services Food and Drug Administration Center for Tobacco Products, 10903 New Hampshire Avenue, Document Control Center, Building 71, Room G335, Silver Spring, MD 20993 Phone:877 287-1373 Email: ctpregulations@fda.hhs.gov |